首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1467705

2024-2032 年按產品類型、服務類型、銀行類型、利用率、應用和地區分類的幹細胞銀行市場報告

Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年，全球IMARC Group細胞銀行市場規模達到80億美元。幹細胞分離、儲存和運輸技術的不斷進步、醫療保健支出的不斷增加、再生醫學的不斷進步以及私人公司的大量投資是推動市場發展的一些因素。

幹細胞銀行是一項革命性的醫學進步，為未來提供了一條生命線。這個過程涉及保存各種來源的幹細胞，例如臍帶血或成人組織。這些細胞具有顯著的再生潛力，是治療從白血病到帕金森氏症等神經退化性疾病等多種疾病的關鍵。幹細胞庫透過在超低溫下低溫冷凍這些生物寶藏來保護它們，確保其存活數十年。其影響是深遠的。家庭可以獲得生物保險，因為這些細胞可以治療捐贈者和遺傳相容的親屬，從而降低免疫排斥的風險。此外，幹細胞研究不斷推出新的治療應用，並有望在個人化醫療方面取得突破。然而，可及性仍然是一個問題，全球的成本和意識各不相同。幹細胞銀行是一項富有遠見的健康投資。它可以開啟一個用患者的細胞治療衰弱性疾病的未來，消除對高風險移植的需要，並開啟醫學科學的新領域。擴大這種變革性技術的獲取和認知對於充分發揮其潛力造福人類至關重要。

全球市場的主要動力是人們對幹細胞在治療癌症、糖尿病和心血管疾病等多種疾病方面的治療潛力的認知不斷提高。廣泛的研究和臨床試驗不斷證明幹細胞療法的功效，激發了醫學專業人士和公眾的想像力，從而推動了這種認知的提升。此外，隨著越來越多的夫婦選擇晚育，延遲生育的趨勢不斷擴大，這增強了人們對臍帶血庫的興趣。父母認知到保存新生兒臍帶血幹細胞作為生物保險的價值，以防他們的孩子或家庭成員面臨未來的醫療挑戰。此外，幹細胞銀行服務的全球化是另一個關鍵驅動力。冷凍保存技術的進步延長了儲存的幹細胞的保存期限，從而可以進行國際運輸和跨境利用。這擴大了市場範圍並促進了幹細胞庫之間的全球合作。此外，政府支持和監管框架變得更有利於幹細胞銀行業務，為投資和成長創造有利的環境。慢性疾病的日益普及以及幹細胞提供個人化治療的潛力鞏固了其作為未來醫療保健關鍵組成部分的地位，確保了市場的持續擴張。

幹細胞銀行市場趨勢/促進因素：

人口老化加劇

人口老化的加劇對市場有正面影響。這種人口結構的變化正在改變全球的醫療保健動態。隨著年齡的成長，他們變得更容易患骨關節炎、心血管疾病等退化性疾病，以及阿茲海默症和帕金森氏症等神經退化性疾病。幹細胞在再生受損或老化組織方面具有巨大前景，為突破性治療和提高老年人的生活品質提供了潛力。不斷成長的老年人口需要更先進的醫療保健解決方案，並且代表了幹細胞銀行服務的龐大客戶群。一些個人和家庭認知到保存從臍帶血或脂肪組織等來源採集的幹細胞的潛力。這些儲存的幹細胞可用於未來的治療，以對抗與年齡相關的健康問題，創造安全感和樂觀感。因此，老齡化人口對幹細胞再生潛力的認知不斷增強，加上他們對改善醫療保健選擇的渴望，是幹細胞銀行服務需求不斷成長的驅動力，為未來幾年的持續成長奠定了基礎。

臨床試驗的接受度不斷提高

對臨床試驗的接受度不斷提高正在刺激市場。臨床試驗對於證明幹細胞療法在各種疾病（從癌症到脊髓損傷）的安全性和有效性至關重要。隨著這些試驗的結果繼續顯示出希望，醫療專業人員、研究人員和公眾對基於幹細胞的治療的信心得到增強。這種日益成長的接受度意味著對幹細胞銀行服務的更大需求。臨床試驗通常需要易於取得且可靠的高品質幹細胞來源，而專門儲存這些細胞的銀行可以滿足這一關鍵需求。研究人員和製藥公司依靠這些銀行提供試驗所需的標準化且保存完好的幹細胞樣本，從而推動市場的成長。此外，臨床試驗的積極成果推動了再生醫學領域的發展，吸引了公共和私營部門的投資，促進創新並擴大幹細胞銀行服務的範圍。這種研究、接受度和投資的良性循環推動著市場。

圍繞胚胎幹細胞使用的倫理擔憂不斷升級

圍繞胚胎幹細胞的使用不斷升級的道德擔憂正在提振市場。由於破壞胚胎，胚胎幹細胞研究長期以來一直是倫理爭論的主題，導致許多地區受到道德和監管限制。這使得幹細胞研究和治療應用的重點轉向了無爭議的來源，例如成體幹細胞和臍帶血。因此，尋求幹細胞療法潛在益處且不受道德困境的個人和機構正在轉向幹細胞銀行。尤其是臍帶血，作為幹細胞的豐富來源而受到關注，而且沒有任何倫理問題。家庭和醫療保健提供者認知到保存這些細胞作為生物保險的價值，為捐贈者和可能相容的家庭成員預防未來的疾病。這種向道德上合理的幹細胞來源的轉變符合大多數幹細胞庫的做法，吸引了更廣泛的客戶群並為行業的成長做出了貢獻。由於道德考量繼續影響公眾輿論和監管決策，市場處於持續擴張的有利位置。

The global stem cell banking market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The increasing improvements in stem cell isolation, storage, and transportation technologies, the rising healthcare expenditure, the growing progress in regenerative medicine, and the heavy investments by private companies are some of the factors propelling the market.

Stem cell banking, a revolutionary medical advancement, offers a lifeline for the future. This process involves preserving stem cells from various sources, such as umbilical cord blood or adult tissues. These cells possess remarkable regenerative potential, holding the key to treating multiple diseases, from leukemia to neurodegenerative conditions like Parkinson's. Stem cell banking safeguards these biological treasures by cryogenically freezing them at ultra-low temperatures, ensuring their viability for decades. The implications are profound. Families can secure a biological insurance policy, as these cells can treat the donor and genetically compatible relatives, reducing the risk of immune rejection. Additionally, stem cell research continues to unveil new therapeutic applications, promising breakthroughs in personalized medicine. However, accessibility remains an issue, with costs and awareness varying globally. Stem cell banking is a visionary investment in health. It can unlock a future where debilitating diseases are treated with the patient's cells, eliminating the need for risky transplants and opening new frontiers in medical science. Expanding access and awareness of this transformative technology is essential to harness its full potential for the benefit of humanity.

The global market is majorly driven by increasing awareness of the therapeutic potential of stem cells in treating a wide array of diseases, including cancer, diabetes, and cardiovascular conditions. This heightened awareness is fueled by extensive research and clinical trials that continually demonstrate the efficacy of stem cell-based therapies, capturing the imagination of medical professionals and the general public. Furthermore, the expanding trend of delayed parenthood, with more couples opting to have children later in life, has intensified interest in umbilical cord blood banking. Parents recognize the value of preserving their newborn's cord blood stem cells as biological insurance should their child or a family member face a future medical challenge. Moreover, the globalization of stem cell banking services is another key driver. Advances in cryopreservation techniques have extended the shelf life of stored stem cells, allowing for international transportation and cross-border utilization. This has widened the market's reach and fostered worldwide collaboration among stem cell banks. Additionally, government support and regulatory frameworks are becoming more conducive to stem cell banking, fostering a favorable environment for investment and growth. The increasing prevalence of chronic diseases and the potential of stem cells to provide personalized treatments solidifies its position as a pivotal component of future healthcare, ensuring the market's continued expansion.

Stem Cell Banking Market Trends/Drivers:

Increasing aging population

The increasing aging population is positively influencing the market. This demographic shift is transforming healthcare dynamics globally. As individuals age, they become more susceptible to degenerative diseases such as Osteoarthritis, cardiovascular conditions, and neurodegenerative disorders like Alzheimer's and Parkinson's. Stem cells hold immense promise in regenerating damaged or aging tissues, offering the potential for groundbreaking treatments and enhanced quality of life for older people. This growing elderly population demands more advanced healthcare solutions and represents a substantial customer base for stem cell banking services. Several individuals and families recognize the potential of preserving their or their loved ones' stem cells, harvested from sources like cord blood or adipose tissue. These stored stem cells can be used in future therapies to combat age-related health issues, creating a sense of security and optimism. As a result, the aging population's increasing awareness of the regenerative potential of stem cells, coupled with their desire for improved healthcare options, is a driving force behind the rising demand for stem cell banking services, positioning the market for sustained growth in the years to come.

Rising acceptance of clinical trials

The rising acceptance of clinical trials is catalyzing the market. Clinical trials are pivotal in demonstrating the safety and efficacy of stem cell-based therapies across various medical conditions, ranging from cancer to spinal cord injuries. As the results of these trials continue to show promise, confidence in stem cell-based treatments is bolstered among medical professionals, researchers, and the general public. This increasing acceptance translates into greater demand for stem cell banking services. Clinical trials often require a readily accessible and reliable source of high-quality stem cells, and banks specializing in storing these cells meet this critical need. Researchers and pharmaceutical companies rely on these banks to provide the standardized and well-preserved stem cell samples required for their trials, thus driving the market's growth. Furthermore, positive outcomes from clinical trials advance the regenerative medicine field and attract investments from both the public and private sectors, fostering innovation and expanding the range of stem cell banking services available. This virtuous cycle of research, acceptance, and investment propels the market.

Escalating ethical concerns surrounding the use of embryonic stem cells

The escalating ethical concerns surrounding the use of embryonic stem cells are bolstering the market. Embryonic stem cell research has long been a subject of ethical debate due to destroying embryos, resulting in moral and regulatory restrictions in many regions. This has shifted the focus of stem cell research and therapeutic applications towards non-controversial sources, such as adult stem cells and cord blood. As a result, individuals and institutions seeking the potential benefits of stem cell therapies without ethical quandaries are turning to stem cell banking. Cord blood, in particular, has gained prominence as a rich source of stem cells without any ethical concerns. Families and healthcare providers recognize the value of preserving these cells as biological insurance against future illnesses for the donor and potentially compatible family members. This shift towards ethically sound stem cell sources aligns with the practices of most stem cell banks, attracting a broader customer base and contributing to the industry's growth. The market is well-positioned for sustained expansion as ethical considerations continue influencing public opinion and regulatory decisions.

Stem Cell Banking Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, service type, bank type, utilization and application.

Breakup by Product Type:

Adult Stem Cells

Human Embryonic Cells

IPS Cells

Adult stem cells dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes adult stem cells, human embryonic cells, and IPS cells. According to the report, adult stem cells represented the largest segment.

Adult stem cells, also known as somatic or tissue-specific, have emerged as a game-changer in regenerative medicine. These cells are ethically uncontroversial, sourced from bone marrow, adipose tissue, and peripheral blood. Their therapeutic potential in treating various ailments, including orthopedic issues, cardiovascular diseases, and autoimmune disorders, is increasingly recognized.

The rising demand for adult stem cell banking services stems from the growing awareness of their versatility and effectiveness. Patients, physicians, and researchers are considering preserving adult stem cells as a proactive approach to future medical challenges. This demand drives competition and innovation within the industry, resulting in improved storage techniques and expanded service offerings. As regenerative medicine continues to advance, the adult stem cell segment stands as a linchpin in the market's overall expansion, promising personalized healthcare solutions for various conditions and securing its position at the forefront of medical progress.

Breakup by Service Type:

Sample Preservation and Storage

Sample Analysis

Sample Processing

Sample Collection and Transportation

Sample preservation and storage dominate the market

The report has provided a detailed breakup and analysis of the market based on the service type. This includes sample preservation and storage, sample analysis, sample processing, and sample collection and transportation. According to the report, sample preservation and storage represented the largest segment.

Sample preservation and storage segment plays a pivotal role in propelling the market. Stem cell therapies have emerged as a revolutionary medical frontier, promising treatments for various diseases and conditions. Consequently, the demand for safe and reliable storage solutions for precious stem cell samples has skyrocketed. These services offered by stem cell banks ensure these valuable biological assets' long-term viability and potency. This crucial service segment encompasses cutting-edge cryopreservation techniques, state-of-the-art storage facilities, and rigorous quality control measures.

In an era where regenerative medicine is gaining prominence, the efficacy of stem cell treatments hinges on the integrity and accessibility of stored samples. The commitment of stem cell banks to maintaining optimal sample conditions instills confidence in healthcare providers and encourages individuals to invest in stem cell banking for their future medical needs. This rising demand for Sample Preservation and Storage services drives the revenue growth of stem cell banks and fuels advancements in biotechnology and medical research, ultimately paving the way for innovative therapies and improved healthcare outcomes.

Breakup by Bank Type:

Private

Public

Private dominates the market

The report has provided a detailed breakup and analysis of the market based on the bank type. This includes private and public. According to the report, private represented the largest segment.

Private stem cell banks cater to the growing trend of individuals and families taking proactive measures to secure their health and that of their loved ones. These banks offer a unique opportunity for clients to preserve their own or their newborn's stem cells, often sourced from cord blood, for potential future medical needs. This personalized approach to healthcare resonates strongly with a wide demographic, ranging from expectant parents seeking to secure their child's health to adults considering their long-term well-being.

The appeal of private stem cell banks lies in the assurance of access and control over one's biological assets a sense of biological insurance. As medical research unveils novel therapies and applications for stem cells, private banks' convenience and peace of mind are significant drivers of market growth. This segment's emphasis on personalized healthcare aligns with the evolving healthcare landscape, cementing its role in shaping the future of medicine and propelling market growth.

Breakup by Utilization:

Used

Unused

Unused dominates the market

The report has provided a detailed breakup and analysis of the market based on the utilization. This includes used and unused. According to the report, unused represented the largest segment.

The unused segment is equally influential, especially with the growing trend toward proactive healthcare. Individuals and families recognize the intrinsic value of preserving stem cells for potential future use, even without immediate medical need. This preventive approach is reinforced by ongoing research revealing new applications for stem cells. The prospect of securing biological insurance against unforeseen health challenges or benefiting from emerging therapies amplifies the demand for stem cell banking services, further solidifying its position as a dynamic force in modern healthcare.

Furthermore, the used segment reflects the escalating clinical adoption of stem cell-based therapies and treatments, spanning various medical conditions from leukemia to spinal cord injuries. As the effectiveness and safety of these therapies become increasingly established through clinical trials and real-world applications, the demand for access to stored stem cell samples surges. This drives the growth of stem cell banking services as patients and healthcare providers seek reliable sources for viable and high-quality stem cells.

Breakup by Application:

Personalized Banking Applications

Research Applications

Clinical Applications

Clinical applications dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes personalized banking applications, research applications, and clinical applications. According to the report, clinical applications represented the largest segment.

Stem cells hold immense potential in regenerative medicine, and clinical applications harness this potential to treat various medical conditions. From neurological disorders like Parkinson's and Alzheimer's to orthopedic injuries and autoimmune diseases, stem cell-based therapies offer new hope for patients worldwide. The availability of well-preserved and diverse stem cell samples from banks is paramount for successful clinical interventions.

Clinical applications encompass established treatments and cutting-edge therapies in various stages of development, including clinical trials. These applications demand various stem cell types, such as hematopoietic, mesenchymal, and induced pluripotent stem cells, each tailored to specific medical needs. Stem cell banks offering a comprehensive array of these resources contribute significantly to the growth of clinical applications in regenerative medicine.

Furthermore, as research expands our understanding of stem cell biology and therapeutic potential, the clinical landscape is poised for continuous evolution. Consequently, the Clinical Applications segment remains a key driver in the stem cell banking market, fostering innovation and offering renewed optimism for patients seeking novel treatments and improved healthcare outcomes.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America plays a pivotal role in driving the growth of the market. With its advanced healthcare infrastructure, robust research and development activities, and a population increasingly aware of the potential benefits of stem cell therapies, the region stands at the forefront of this burgeoning industry. In the region, stem cell banking is viewed as a proactive health measure and a source of hope for patients suffering from a range of debilitating conditions.

In particular, the United States and Canada have witnessed significant investments in private stem cell banks driven by a combination of healthcare advancements and a culture of health-consciousness. Furthermore, the region's regulatory environment has been relatively supportive, further bolstering market growth by fostering a favorable climate for stem cell banking services.

As clinical trials for stem cell-based therapies expand, and research endeavors continue to flourish in North America, the demand for high-quality stem cell preservation and banking services continues to rise, making this region a powerhouse in shaping the future of stem cell banking.

Competitive Landscape:

Top companies are pivotal in strengthening market growth through a multifaceted approach. These industry leaders invest heavily in cutting-edge research and development, driving innovation in stem cell preservation and analysis techniques. They continually enhance the quality and viability of stored stem cells, instilling confidence in their clients and the medical community. These companies also prioritize extensive collaborations with research institutions, pharmaceutical firms, and healthcare providers. This collaborative spirit fosters the advancement of stem cell-based therapies, expanding their applications and creating a growing demand for banking services. Moreover, top firms actively engage in public awareness campaigns, educating individuals and families about the potential benefits of stem cell banking. This outreach grows the customer base and fuels interest in stem cell research and regenerative medicine. Additionally, their international presence and ability to provide cross-border services amplify market reach and accessibility, further driving growth.

The report has provided a comprehensive analysis of the competitive landscape in the stem cell banking market. Detailed profiles of all major companies have also been provided.

CBR Systems Inc.

China Cord Blood Corporation

Cordlife

Cordvida

Cryo-Cell International, Inc.

Cryo-Save AG (A Group of Esperite)

Cryoviva India

Lifecell

Smart Cells International Ltd

Viacord

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In July 2023, Cordlife announced advanced research on Mesenchymal Stem Cell Secretome-based products for treating Osteoarthritis.

In March 2022, Cryo-Cell International, Inc. revealed its acquisition of a 56,000-square-foot facility in the Research Triangle, North Carolina, within the Regional Commerce Center. This acquisition is contingent upon the fulfillment of standard closing conditions.

Key Questions Answered in This Report

1. What was the size of the global stem cell banking market in 2023?
2. What is the expected growth rate of the global stem cell banking market during 2024-2032?
3. What are the key factors driving the global stem cell banking market?
4. What has been the impact of COVID-19 on the global stem cell banking market?
5. What is the breakup of the global stem cell banking market based on the product type?
6. What is the breakup of the global stem cell banking market based on the service type?
7. What is the breakup of the global stem cell banking market based on the bank type?
8. What is the breakup of the global stem cell banking market based on the utilization?
9. What is the breakup of the global stem cell banking market based on the application?
10. What are the key regions in the global stem cell banking market?
11. Who are the key players/companies in the global stem cell banking market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Stem Cell Banking Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product Type
5.5 Market Breakup by Service Type
5.6 Market Breakup by Bank Type
5.7 Market Breakup by Utilization
5.8 Market Breakup by Application
5.9 Market Breakup by Region
5.10 Market Forecast

6 Market Breakup by Product Type

6.1 Adult Stem Cells
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Human Embryonic Cells
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 IPS Cells
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Service Type

7.1 Sample Preservation and Storage
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Sample Analysis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Sample Processing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Sample Collection and Transportation
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Bank Type

8.1 Private
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Public
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Utilization

9.1 Used
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Unused
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Application

10.1 Personalized Banking Applications
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Research Applications
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Clinical Applications
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
11.2 Europe
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
11.3 Asia Pacific
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
11.4 Middle East and Africa
- 11.4.1 Market Trends
- 11.4.2 Market Forecast
11.5 Latin America
- 11.5.1 Market Trends
- 11.5.2 Market Forecast

12 Global Stem Cell Banking Industry: SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Global Stem Cell Banking Industry: Value Chain Analysis

14 Global Stem Cell Banking Industry: Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Global Stem Cell Banking Industry: Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 CBR Systems Inc.
- 16.3.2 China Cord Blood Corporation
- 16.3.3 Cordlife
- 16.3.4 Cordvida
- 16.3.5 Cryo-Cell International, Inc.
- 16.3.6 Cryo-Save AG (A Group of Esperite)
- 16.3.7 Cryoviva India
- 16.3.8 Lifecell
- 16.3.9 Smart Cells International Ltd
- 16.3.10 Viacord

簡介目錄圖表

List of Figures

Figure 1: Global: Stem Cell Banking Market: Major Drivers and Challenges
Figure 2: Global: Stem Cell Banking Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Stem Cell Banking Market: Breakup by Product Type (in %), 2023
Figure 4: Global: Stem Cell Banking Market: Breakup by Service Type (in %), 2023
Figure 5: Global: Stem Cell Banking Market: Breakup by Bank Type (in %), 2023
Figure 6: Global: Stem Cell Banking Market: Breakup by Utilization (in %), 2023
Figure 7: Global: Stem Cell Banking Market: Breakup by Application (in %), 2023
Figure 8: Global: Stem Cell Banking Market: Breakup by Region (in %), 2023
Figure 9: Global: Stem Cell Banking Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Stem Cell Banking Industry: SWOT Analysis
Figure 11: Global: Stem Cell Banking Industry: Value Chain Analysis
Figure 12: Global: Stem Cell Banking Industry: Porter's Five Forces Analysis
Figure 13: Global: Stem Cell Banking (Adult Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Stem Cell Banking (Adult Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Stem Cell Banking (Human Embryonic Cells) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Stem Cell Banking (Human Embryonic Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Stem Cell Banking (IPS Cells) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Stem Cell Banking (IPS Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Stem Cell Banking (Sample Preservation and Storage) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Stem Cell Banking (Sample Preservation and Storage) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Stem Cell Banking (Sample Analysis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Stem Cell Banking (Sample Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Stem Cell Banking (Sample Processing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Stem Cell Banking (Sample Processing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Stem Cell Banking (Sample Collection and Transportation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Stem Cell Banking (Sample Collection and Transportation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Stem Cell Banking (Private) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Stem Cell Banking (Private) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Stem Cell Banking (Public) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Stem Cell Banking (Public) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Stem Cell Banking (Used) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Stem Cell Banking (Used) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Stem Cell Banking (Unused) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Stem Cell Banking (Unused) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Stem Cell Banking (Personalized Banking Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Stem Cell Banking (Personalized Banking Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Stem Cell Banking (Research Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Stem Cell Banking (Research Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Stem Cell Banking (Clinical Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Stem Cell Banking (Clinical Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North America: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: North America: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Europe: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Europe: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Asia Pacific: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Asia Pacific: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Middle East and Africa: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Middle East and Africa: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Latin America: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Latin America: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

Table 1: Global: Stem Cell Banking Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Stem Cell Banking Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Stem Cell Banking Market Forecast: Breakup by Service Type (in Million US$), 2024-2032
Table 4: Global: Stem Cell Banking Market Forecast: Breakup by Bank Type (in Million US$), 2024-2032
Table 5: Global: Stem Cell Banking Market Forecast: Breakup by Utilization (in Million US$), 2024-2032
Table 6: Global: Stem Cell Banking Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 7: Global: Stem Cell Banking Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Stem Cell Banking Market Structure
Table 9: Global: Stem Cell Banking Market: Key Players

02-2729-4219

+886-2-2729-4219